Late treatment study
et al., Turk. J. Med. Sci., doi:10.3906/sag-2006-173 (Peer Reviewed)
Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU
Observational study of 174 hospitalized patients in Turkey, median age 45.4, 23 treated with HC
Q, 113 with HC
Q+AZ, and 32 with regimens including favipiravir. 75% reduction in the median time to clinical improvement for HC
Q+AZ vs. FAV, RR 0.25, p<0.001. 83% reduction for HC
Q. However, there was significant confounding by indication.
There were no significant adverse events.
Please send us corrections, updates, or comments.